Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.330
+0.180 (5.71%)
At close: Mar 9, 2026, 4:00 PM EDT
3.370
+0.040 (1.20%)
After-hours: Mar 9, 2026, 7:52 PM EDT

Sana Biotechnology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-244.17-266.76-283.26-269.48-355.93
Upgrade
Depreciation & Amortization
12.7515.517.5415.6311.07
Upgrade
Asset Writedown & Restructuring Costs
44.611.897.01--
Upgrade
Stock-Based Compensation
25.4637.6835.5338.3422.36
Upgrade
Other Operating Activities
27.63-10.28-49.03-82.0861.64
Upgrade
Change in Accounts Payable
-3.551.381.031.06-0.27
Upgrade
Change in Other Net Operating Assets
-6.57-2.5617.586.4810.07
Upgrade
Operating Cash Flow
-143.83-223.15-253.58-290.05-251.05
Upgrade
Capital Expenditures
-0.94-33.43-20.03-20.88-29.86
Upgrade
Sale of Property, Plant & Equipment
1.43----
Upgrade
Investment in Securities
-40.7350.88192.04231.44-211.36
Upgrade
Other Investing Activities
-----4.57
Upgrade
Investing Cash Flow
-40.2417.45172.01210.56-245.8
Upgrade
Long-Term Debt Issued
-7.74---
Upgrade
Long-Term Debt Repaid
-0.35----
Upgrade
Net Debt Issued (Repaid)
-0.357.74---
Upgrade
Issuance of Common Stock
129.08192.0131.654.91631.75
Upgrade
Financing Cash Flow
128.73199.7531.654.91631.75
Upgrade
Net Cash Flow
-55.33-5.95-49.92-74.58134.9
Upgrade
Free Cash Flow
-144.77-256.58-273.61-310.93-280.92
Upgrade
Free Cash Flow Per Share
-0.57-1.11-1.41-1.65-1.69
Upgrade
Levered Free Cash Flow
-53.57-168.3-206.93-140.89-138.16
Upgrade
Unlevered Free Cash Flow
-53.57-168.3-206.93-140.89-138.16
Upgrade
Change in Working Capital
-10.11-1.1918.617.549.8
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.